BBP-20225 Yellow
Cc1nc(Nc2cc(C)[nH]n2)cc(C2CCN(Cc3ccnc(C)c3F)CC2)n1
0.467
Platform Score
2D Structure
C21H26FN7 | Exact mass: 395.2234
Key Metrics
-6.6
Vina (kcal/mol)
#2834
Docking Rank
1
Hinge Binder
83
TPSA
395
MW
2
HBD
3.8
SlogP
Display Controls
PLK4 Docking Result
-6.62
kcal/mol (molecular docking)
| Docking Rank | #2834 of 1,249 |
| Consensus Score | 0.1466 |
| Receptor | PLK4 (PDB: 4YUR) |
| Selective | No |
Selectivity Profile
ADMET Profile
| BBB (BOILED-Egg) | BBB- (non-penetrant) |
| ADMET Status | Pass (no hard fails) |
| hERG Risk | pIC50 0.9 (low risk) |
| AMES Mutagenicity | Negative |
| Efflux Risk (P-gp) | Non-substrate — low efflux risk. ER predicted <2.0 |
| Intestinal Absorption | High |
| 3D PSA | 73.4 A² (CNS-favorable) |
| MDCK Perm (predicted) | -4.75 log Papp (good) |
| CYP3A4 Inhibitor | Inhibitor |
| Hepatotoxicity | Negative |
Flags: ["CYP3A4_inhibitor"]
CNS Drug-Likeness
Physicochemical Properties
| Molecular Weight | 395.49 Da |
| TPSA | 82.6 A^2 |
| HBD | 2 |
| HBA | 6 |
| SlogP | 3.78 |
| Fsp3 | 0.429 |
| Rotatable Bonds | 5 |
| Rings | 4 (3 aromatic) |
| QED | 0.684 |
| SA Score | 2.88 (1=easy, 10=hard) |
| CNS MPO | 2.32 / 4.0 |
| Formula | C21H26FN7 |
| Exact Mass | 395.2234 |
Classification
| Scaffold (Murcko) | C1CCC(CC2CCC(C3CCCC(CC4CCCC4)C3)CC2)CC1 |
| Source Versions | v15,v16,v17 |
| Best Source Score | 0.6962 |
| Best Source Rank | #272 |
| Hinge Binder | Aminopyrazole DAD |
| InChIKey | RUJPGFCLAQVGPX-UHFFFAOYSA-N |
| Filter Pass | Yes |
Retrosynthetic Analysis
Retrosynthetic analysis not yet run for this compound.
About
Retrosynthetic analysis decomposes the target molecule into purchasable building blocks using learned reaction templates.
A feasible route means the molecule can theoretically be synthesized from commercially available starting materials.
Min steps indicates the shortest synthesis route found.